About Bavium Pharmaceuticals Private Limited
Data last updated:
Bavium Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC306640. Its GSTIN is 27AAHCB7148Q1ZY (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manish Baliram Shinde and Vaijanath Balaji Dahiphale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.566 Karmad Tq & Dist.Aurangabad, Maharashtra, India – 431007.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.97 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹45,167 (net margin 1.7%) and EBITDA of ₹89,241 (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 105% over five years.
For more details, the company can be reached via its website bavium.com.
Company details
Contact details
Bavium Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its website is bavium.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No.566 Karmad Tq & Dist.Aurangabad, Maharashtra, India – 431007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bavium Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bavium Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bavium Pharmaceuticals Private Limited, buy the company report.
Financials of Bavium Pharmaceuticals Private Limited
FY 2025 filings availableBavium Pharmaceuticals Private Limited reported revenue of ₹25.97 Lakh (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 105% over five years, including 7% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹89,241 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45,167 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bavium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bavium Pharmaceuticals Private Limited
Bavium Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Baliram Shinde | Director | 16 Mar 2018 | 8 Years 7 Months | Current |
| Vaijanath Balaji Dahiphale | Director | 15 Jul 2025 | 1 Years 3 Months | Current |
| Madhuri Rajendra Patil | Director | 15 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Bavium Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glaze Healthcare Private Limited | ₹26.03 Lakh (FY 2018) | -25.0% | Agra, Uttar Pradesh, India | |||
| Roussel Laboratories Private Limited | ₹26.01 Lakh (FY 2025) | 0.0% | Ahmedabad, Gujarat, India | |||
| Curestar Pharmaceuticals Private Limited | ₹25.98 Lakh (FY 2025) | 65.0% | Korba, Maharashtra, India | |||
| Bavium Pharmaceuticals Private Limitedthis company | ₹25.97 Lakh (FY 2024) | ₹45,167 | 1.7% | 7.0% | Aurangabad, Maharashtra, India | |
| Twwif Pharmaceuticals Private Limited | ₹25.94 Lakh (FY 2025) | 92.0% | Delhi, India |
To see the full peer comparison of Bavium Pharmaceuticals Private Limited, buy the company report.
Auditor
Bavium Pharmaceuticals Private Limited is audited by HEMANT SHAH & ASSOCIATES LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HEMANT SHAH & ASSOCIATES LLP | FY 2020 | 120816W |
Shareholding
The shareholding of Bavium Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bavium Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bavium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bavium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bavium Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCB7148Q1ZY | Maharashtra | Active | 06 Dec 2018 |
To see the full GST registrations and return filing status of Bavium Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bavium Pharmaceuticals Private Limited has 4 board changes on record since 2018: 4 appointments. The latest: Madhuri Rajendra Patil was appointed as Director on 15 Jul 2025.
Frequently asked questions
Bavium Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2018 (8+ years old) and is registered under CIN U74999MH2018PTC306640.
Bavium Pharmaceuticals has 3 current directors:
- Manish Baliram Shinde - Director
- Vaijanath Balaji Dahiphale - Director
- Madhuri Rajendra Patil - Director
The latest financial statements of Bavium Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Bavium Pharmaceuticals is 27AAHCB7148Q1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bavium Pharmaceuticals is U74999MH2018PTC306640. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bavium Pharmaceuticals was incorporated on 16 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bavium Pharmaceuticals by revenue are Glaze Healthcare Private Limited, Roussel Laboratories Private Limited, Curestar Pharmaceuticals Private Limited, Twwif Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Madhuri Rajendra Patil was appointed as Director on 15 Jul 2025. Vaijanath Balaji Dahiphale was appointed as Director on 15 Jul 2025. Manish Baliram Shinde was appointed as Director on 16 Mar 2018. Bavium Pharmaceuticals has 4 board changes on record in total.
Bavium Pharmaceuticals can be reached through the website bavium.com. Its registered office is in Aurangabad, Maharashtra, India.
The registered office of Bavium Pharmaceuticals is at H.No.566 Karmad Tq & Dist.Aurangabad, Maharashtra, India – 431007.
Bavium Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.